REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 32 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2023. The put-call ratio across all filers is 1.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,283,176 | -16.1% | 877,700 | +0.7% | 0.00% | -100.0% |
| Q2 2023 | $5,105,818 | +342.6% | 871,300 | +216.5% | 0.00% | – |
| Q1 2023 | $1,153,541 | -17.0% | 275,308 | -15.8% | 0.00% | – |
| Q4 2022 | $1,389,028 | +137.8% | 326,830 | -11.1% | 0.00% | – |
| Q3 2022 | $584,000 | +114.7% | 367,518 | +48.4% | 0.00% | – |
| Q2 2022 | $272,000 | +38.1% | 247,600 | +209.1% | 0.00% | – |
| Q1 2022 | $197,000 | +23.1% | 80,103 | +41.2% | 0.00% | – |
| Q4 2021 | $160,000 | +48.1% | 56,746 | +113.1% | 0.00% | – |
| Q3 2021 | $108,000 | – | 26,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $5,832,000 | 1.16% |
| EMC Capital Management | 75,835 | $257,000 | 0.15% |
| ARMISTICE CAPITAL, LLC | 714,700 | $3,473,000 | 0.06% |
| Tower Research Capital LLC (TRC) | 12,484 | $61,000 | 0.00% |
| UBS Group AG | 2,033 | $10,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| NORTHERN TRUST CORP | 10,584 | $51,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 67,724 | $329,000 | 0.00% |
| Renaissance Technologies | 11,250 | $55,000 | 0.00% |